¼¼°èÀÇ ½Å°æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
Nerve Monitoring Devices
»óǰÄÚµå : 1757801
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 274 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,009,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,027,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½Å°æ ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 16¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½Å°æ ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 16¾ï ´Þ·¯¿¡ À̸£°í, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 3.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ³úÆÄ°è´Â CAGR 2.8%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 5¾ï 6,730¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±ÙÀüµµ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 2.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 3¾ï 5,100¸¸ ´Þ·¯, Áß±¹Àº CAGR 6.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½Å°æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2024³â¿¡ 3¾ï 5,100¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 3¾ï 790¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.1%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.3%¿Í 2.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.9%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ½Å°æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

½Å°æ ¸ð´ÏÅ͸µ ±â±â°¡ ¼ö¼ú ÇöÀå¿¡¼­ Áß¿äÇÏ°Ô ¿©°ÜÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½Å°æ ¸ð´ÏÅ͸µ ±â±â´Â ½Å°æ ±â´ÉÀ» À¯ÁöÇÏ´Â °ÍÀÌ È¯ÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÁÙÀÌ´Â µ¥ ÇʼöÀûÀÎ Çö´ë ¼ö¼ú¿¡¼­ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÁÖ·Î ºÎÁÖÀÇ·Î ÀÎÇÑ ½Å°æ ¼Õ»óÀÇ À§ÇèÀÌ ³ôÀº ôÃß, µÎ°æºÎ, ¸»ÃʽŰæ°è¸¦ Æ÷ÇÔÇÑ º¹ÀâÇÑ ¼ö¼ú¿¡ ÁÖ·Î »ç¿ëµË´Ï´Ù. ½Ç½Ã°£ ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µ(IONM)À» ÅëÇØ ¿Ü°ú ÀÇ»ç´Â ÇØºÎ ¹× Á¶Á÷ Á¶ÀÛ Áß ½Å°æ ±â´ÉÀ» Áï°¢ÀûÀ¸·Î Çǵå¹éÇÏ¿© ¿îµ¿ ½Å°æ°ú °¨°¢ ½Å°æÀ» ½Äº°ÇÏ°í º¸È£ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½Å°æ¿Ü°ú, À̺ñÀÎÈİú, Á¤Çü¿Ü°ú, ½ÉÇ÷°ü ºÐ¾ß¿¡¼­ ¼ö¼úÀÇ º¹À⼺°ú ºóµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¤È®ÇÏ°í ¹ÝÀÀ¼ºÀÌ ¶Ù¾î³ª¸ç »ç¿ëÇϱ⠽¬¿î ½Å°æ ¸ð´ÏÅ͸µ µµ±¸¿¡ ´ëÇÑ ÀÓ»óÀû ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼ú°ú ·Îº¿ º¸Á¶ ¼ö¼úÀÇ µµÀÔÀÌ ÁøÇàµÊ¿¡ µû¶ó ¿ÀÂ÷ ¹üÀ§°¡ »ó´çÈ÷ Á¼¾ÆÁö°í ÀÖ½À´Ï´Ù. ½Å°æ ¸ð´ÏÅ͸µ ±â±â´Â Á¤È®µµ¸¦ ³ôÀÌ°í ¼º´ë ¸¶ºñ, »çÁö ¸¶ºñ, ¿ä½Ç±Ý°ú °°Àº ½Å°æ Àå¾ÖÀÇ °¡´É¼ºÀ» ÁÙÀÓÀ¸·Î½á ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â´É º¸Á¸ ¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½Å°æ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº °íÀ§Çè ¼ö¼úÀÇ Ç¥ÁØ ÇÁ·ÎÅäÄÝ·Î È®°íÈ÷ ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

Á¤È®µµ¿Í ÀÓ»óÀû À¯¿ë¼ºÀ» ³ôÀÌ´Â ±â¼ú Çõ½ÅÀ̶õ?

½Å°æ ¸ð´ÏÅ͸µÀÇ »óȲÀº ½ÅÈ£ °¨Áö, »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º µðÀÚÀÎ ¹× ½Ã½ºÅÛ ÅëÇÕÀÇ °³¼±À¸·Î ´«¿¡ ¶ç´Â ±â¼úÀû º¯ÇõÀ» °Þ°í ÀÖ½À´Ï´Ù. ±ÙÀüµµ(EMG) ±â¹Ý ÀåÄ¡, ü¼º°¨°¢À¯¹ßÀüÀ§(SSEP) ½Ã½ºÅÛ, ¿îµ¿À¯¹ßÀüÀ§(MEP) ±â¼úÀº ½ÇÁ¦ ½Å°æ ½ÅÈ£¿Í ¼ö¼úÀÇ Àΰø¹°À» ±¸º°ÇÏ´Â ´É·Â¿¡¼­ ´õ¿í Á¤±³ÇØÁö°í ÀÖ½À´Ï´Ù. ÷´Ü ½Ã½ºÅÛÀº ÇöÀç ³ëÀÌÁî °¨¼Ò ¾Ë°í¸®Áò, ¸ÂÃãÇü °æ°í, ´ÙÁß Ã¤³Î ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãß°í ÀÖ¾î º¸´Ù Á¤È®ÇÑ ½Å°æ ¸ÅÇΰú ¾ÈÀüÇÑ ¼ö¼ú Ž»öÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¹«¼± ÇÁ·Îºê, ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º, AI Áö¿ø ÇØ¼® ¸ðµâÀº ÀÇ»ç°áÁ¤ÀÇ Á¤È®¼ºÀ» ³ôÀ̸鼭 ¼ö¼ú Áß »ç¿ëÀ» ´õ¿í ´Ü¼øÈ­Çϰí ÀÖ½À´Ï´Ù. ¼ö¼ú ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛ ¹× ·Îº¿ Áö¿ø Ç÷§Æû°úÀÇ ÅëÇÕÀ» ÅëÇØ ½Å°æ ¸ð´ÏÅ͸µÀÌ º¸Á¶ÀûÀÎ ±â´ÉÀÌ ¾Æ´Ñ ¼ö¼ú °èȹ ¹× ¼ö¼ú ¼öÇàÀÇ ÇÙ½ÉÀÌ µÇ´Â ¿øÈ°ÇÑ ¿öÅ©Ç÷ο츦 ±¸ÃàÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÛ°í ÈÞ´ë °¡´ÉÇÑ ½Å°æ ¸ð´ÏÅ͸µ ±â±â´Â °ø°£°ú ÀÚ¿øÀÇ Á¦¾àÀ¸·Î ÀÎÇØ »ç¿ëÀÌ Á¦ÇÑÀûÀ̾ú´ø ¿Ü·¡ ¹× ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿¡ Æø³Ð°Ô Àû¿ëµÉ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¾ÈÀü¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ½Å°æ ¸ð´ÏÅ͸µÀÌ È¿°úÀûÀ¸·Î Àû¿ëµÉ ¼ö ÀÖ´Â ¼ö¼úÀÇ ¹üÀ§¸¦ ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

ÀÇ·á½Ã¼³ Àü¹ÝÀÇ ÃÖÁ¾ »ç¿ë ÆÐÅÏÀº ¾î¶»°Ô º¯È­Çϰí Àִ°¡?

½Å°æ ¸ð´ÏÅ͸µ ±â±âÀÇ »ç¿ëÀº ´ëÇк´¿ø°ú 3Â÷ ÀÇ·á¼¾ÅͻӸ¸ ¾Æ´Ï¶ó Áö¿ª º´¿ø°ú ¿Ü·¡ ¼ö¼ú ½Ã¼³·Î ºü¸£°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È®»êÀÇ ¹è°æ¿¡´Â ½Å°æ º¸È£ÀÇ ¸ð¹ü »ç·Ê°¡ Ç¥ÁØÈ­µÇ°í ¿Ü°ú ÀÇ»çµéÀÌ ½Å°æ ¸ð´ÏÅ͸µ ÇÁ·ÎÅäÄÝ¿¡ Àͼ÷ÇØÁ³±â ¶§¹®ÀÔ´Ï´Ù. °©»ó¼± ÀýÁ¦¼ú, ÀÌÇϼ± ÀýÁ¦¼ú, ôÃß °¨¾Ð¼ú, Á¤Çü¿Ü°úÀû °üÀý º¹¿ø¼ú°ú °°Àº ´ë±Ô¸ð ¼ö¼úÀº ÀÌÁ¦ À§Çè °¨¼Ò ¹× ǰÁú º¸ÁõÀÇ ÀÏȯÀ¸·Î ¼ö¼ú Áß ½Å°æ ¸ð´ÏÅ͸µÀ» ÀÏ»óÀûÀ¸·Î µµÀÔÇϰí ÀÖ½À´Ï´Ù.

½Å°æ ±¸Á¶°¡ ´õ Ãë¾àÇÑ ¼Ò¾Æ ¹× ³ëÀÎ ¼ö¼ú¿¡¼­µµ ½Å°æ ¸ð´ÏÅ͸µ µµ±¸ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å°æ ¸ð´ÏÅ͸µÀÌ ¿Ü°ú ¼ö·Ã ÇÁ·Î±×·¥ÀÇ Ä¿¸®Å§·³¿¡ Æ÷ÇԵDZ⠽ÃÀÛÇßÀ¸¸ç, ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» ¼±ÅÃÀÌ ¾Æ´Ñ Çʼö·Î ¿©±â´Â »õ·Î¿î ¼¼´ëÀÇ ¿Ü°ú ÀÇ»çµéÀÌ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¼Ò¼ÛÀ» ÃÖ¼ÒÈ­ÇÏ°í ¼ö¼ú ÈÄ È¸º¹ ÁöÇ¥¸¦ Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ÀÇ·á ½Ã½ºÅÛÀº ¼ö¼ú Ä¡·á ÆÐŰÁöÀÇ ÀϺηΠ½Å°æ ¸ð´ÏÅ͸µ ±â±â¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. ¾ÈÀü, ±³À°, È¿À²¼ºÀ̶ó´Â ¼¼ °¡Áö ¸ñÇ¥°¡ ¼­·Î ¸Â¹°¸®¸é¼­ ´õ ¸¹Àº ÀÇ·á ÇöÀå¿¡¼­ÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

½Å°æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

½Å°æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ¼ö¼ú ¼ö¿ä, ±â¼ú ÅëÇÕ, Ä¡·á ±âÁØÀÇ ÁøÈ­¿Í °ü·ÃµÈ ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ôÃß, µÎ°³°ñ, À̺ñÀÎÈİú, Á¤Çü¿Ü°ú¿Í °°Àº º¹ÀâÇÑ ¼ö¼úÀÌ Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, ½Å°æ ¼Õ»óÀÇ À§ÇèÀÌ Àֱ⠶§¹®¿¡ ½Ç½Ã°£ ±â´ÉÀû ÁöħÀÌ ÇÊ¿äÇÕ´Ï´Ù. ȯÀÚÀÇ ¾ÈÀüÀÌ ¼ö¼ú ¼º°úÀÇ ÇÙ½É ÁöÇ¥°¡ µÇ¸é¼­, IONM ÀåºñÀÇ »ç¿ëÀº ÀÓÀÇÀûÀÎ °Í¿¡¼­ ÇʼöÀûÀÎ °ÍÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù.

º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), Àü¹® Ŭ¸®´ÐÀÇ ÃÖÁ¾ ¿ëµµ È®´ë°¡ ½ÃÀå ħÅõ¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú°ú ·Îº¿ º¸Á¶ ¼ö¼úÀÇ ±Þ¼ÓÇÑ º¸±ÞÀ¸·Î Ãֽмö¼ú½Ç ±â¼ú°ú ¿øÈ°ÇÏ°Ô ÅëÇÕµÉ ¼ö ÀÖ´Â ½Å°æ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú ÈÄ Ç°Áú ÁöÇ¥¿Í ÇÕº´Áõ °¨¼Ò¸¦ °­Á¶ÇÏ´Â ÀÇ·á ±ÔÁ¦´Â ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ Ç¥ÁØ ¼ö¼ú ¿öÅ©Ç÷οìÀÇ ÀϺηΠ½Å°æ ¸ð´ÏÅ͸µ µµ±¸¸¦ äÅÃÇϵµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù.

¸ð´ÏÅ͸µ ¹æ¹ý, µ¥ÀÌÅÍ ºÐ¼® ¹× ±â±â ÀÎü°øÇÐÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀº ÀÓ»óÀÇÀÇ ½Å·Ú¼º°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. °³¼±µÈ º¸Çè »óȯ°ú ¹®¼­È­µÈ ½Å°æ ¸ð´ÏÅ͸µÀÇ ÀÇ·á¹ýÀû ÀÌÁ¡¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡µéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ±â±âÀÇ °¡Ä¡ Á¦¾ÈÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, ½Å°æ ¸ð´ÏÅ͸µ ±â±â´Â Àü ¼¼°èÀûÀ¸·Î ¹Ì·¡ ÁöÇâÀûÀÎ ¿Ü°ú ÀÇ·áÀÇ ÇÙ½É ÃàÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

±â¼ú(³úÆÄ, ±ÙÀüµµ, ÇÇÁúÀüµµ, À¯¹ß ÀüÀ§), Á¦Ç°(¸ð´ÏÅÍ, Àü±Ø, º¸Á¶ Á¦Ç°)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 34°³»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLMÀ̳ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Nerve Monitoring Devices Market to Reach US$1.6 Billion by 2030

The global market for Nerve Monitoring Devices estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Electroencephalogram, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$567.3 Million by the end of the analysis period. Growth in the Electromyography segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$351.0 Million While China is Forecast to Grow at 6.1% CAGR

The Nerve Monitoring Devices market in the U.S. is estimated at US$351.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$307.9 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Nerve Monitoring Devices Market - Key Trends & Drivers Summarized

Why Are Nerve Monitoring Devices Gaining Critical Importance in Surgical Settings?

Nerve monitoring devices are becoming indispensable tools in modern surgical procedures, where preserving neural function is essential to improving patient outcomes and reducing postoperative complications. These systems are primarily used during complex surgeries involving the spine, head and neck, or peripheral nervous system, where there is a high risk of inadvertent nerve damage. Real-time intraoperative neuromonitoring (IONM) allows surgeons to identify and protect motor and sensory nerves by providing immediate feedback on nerve function during dissection and tissue manipulation.

The rising complexity and frequency of surgeries in neurosurgery, otolaryngology, orthopedic, and cardiovascular fields are driving the clinical need for accurate, responsive, and user-friendly nerve monitoring tools. With the increasing adoption of minimally invasive and robot-assisted surgeries, the margin for error has narrowed considerably. Nerve monitoring devices address this challenge by enhancing precision and reducing the likelihood of neurological deficits such as vocal cord paralysis, limb weakness, or incontinence. This growing focus on function-preserving surgeries has firmly positioned nerve monitoring systems as standard protocol in high-risk procedures.

What Technological Innovations Are Enhancing Accuracy and Clinical Utility?

The nerve monitoring landscape is undergoing a technological transformation, marked by improvements in signal detection, user interface design, and system integration. Electromyography (EMG)-based devices, somatosensory evoked potential (SSEP) systems, and motor evoked potential (MEP) technologies are becoming more refined in their ability to differentiate real neural signals from surgical artifacts. Advanced systems now feature noise-reduction algorithms, customizable alerts, and multi-channel monitoring capabilities that allow for more precise nerve mapping and safer surgical navigation.

Wireless probes, touchscreen interfaces, and AI-enabled interpretation modules are further simplifying intraoperative use while enhancing decision-making accuracy. Integration with surgical navigation systems and robotic-assisted platforms is creating seamless workflows where nerve monitoring is not an auxiliary function but a core component of surgical planning and execution. Additionally, compact and portable nerve monitoring units are enabling broader deployment in outpatient and ambulatory surgical centers, where space and resource constraints previously limited usage. These innovations are not only improving safety but also expanding the scope of procedures where nerve monitoring can be effectively applied.

How Are End-Use Patterns Shifting Across Healthcare Facilities?

The use of nerve monitoring devices is rapidly expanding beyond academic hospitals and tertiary care centers into community hospitals and outpatient surgical facilities. This diffusion is being driven by the standardization of best practices in nerve protection, as well as increased surgeon familiarity with neuromonitoring protocols. High-volume procedures such as thyroidectomy, parotidectomy, spinal decompression, and orthopedic joint repair are now routinely incorporating intraoperative nerve monitoring as part of risk mitigation and quality assurance efforts.

Pediatric and geriatric surgeries, where neural structures may be more vulnerable, are also witnessing increased use of neuromonitoring tools. Moreover, surgical training programs are beginning to incorporate nerve monitoring into curricula, which is fostering a new generation of surgeons who view these systems as essential rather than optional. Health systems aiming to minimize litigation and enhance postoperative recovery metrics are adopting nerve monitoring devices as part of bundled surgical care packages. The convergence of safety, education, and efficiency objectives is accelerating institutional adoption across a broader range of care settings.

What Factors Are Driving Growth in the Nerve Monitoring Devices Market?

The growth in the nerve monitoring devices market is driven by several key factors related to surgical demand, technology integration, and evolving care standards. A primary driver is the global increase in complex surgical procedures-especially spine, cranial, ENT, and orthopedic operations-where the risk of nerve injury necessitates real-time functional guidance. As patient safety becomes a core metric in surgical outcomes, the use of IONM devices is transitioning from discretionary to essential.

End-use expansion across hospitals, ambulatory surgical centers, and specialized clinics is further boosting market penetration. The rapid adoption of minimally invasive and robotic-assisted surgeries is creating a need for nerve monitoring systems that can integrate seamlessly with modern operating room technologies. Additionally, healthcare regulations emphasizing postoperative quality metrics and complication reduction are encouraging providers to adopt neuromonitoring tools as part of standard surgical workflows.

Ongoing advancements in monitoring modalities, data interpretation, and device ergonomics are also increasing clinician confidence and usability. Reimbursement improvements and rising awareness among healthcare professionals about the medico-legal advantages of documented nerve monitoring are reinforcing the device’s value proposition. Collectively, these factors are propelling strong market growth, making nerve monitoring devices a core pillar of future-ready surgical care across the globe.

SCOPE OF STUDY:

The report analyzes the Nerve Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Electroencephalogram, Electromyography, Electrocorticography, Evoked Potential); Product (Monitor, Electrodes, Ancillary Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â